{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:22:32Z","timestamp":1780590152633,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaci.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T11:01:15Z","timestamp":1556190075000},"page":"44-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["HLA- and immune-mediated adverse drug reactions: Another hit with vancomycin"],"prefix":"10.1016","volume":"144","author":[{"given":"Munir","family":"Pirmohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.04.009_bib1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.04.009_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2019.04.009_bib3","author":"O'Neill"},{"key":"10.1016\/j.jaci.2019.04.009_bib4","doi-asserted-by":"crossref","first-page":"k2400","DOI":"10.1136\/bmj.k2400","article-title":"Risk of methicillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study","volume":"361","author":"Blumenthal","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2019.04.009_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.02.002","article-title":"Vancomycin-associated drug-induced hypersensitivity syndrome (DIHS)","author":"Madigan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.04.009_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.04.009_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.12659\/AJCR.899149","article-title":"DRESS syndrome caused by cross-reactivity between vancomycin and subsequent teicoplanin administration: a case report","volume":"17","author":"Miyazu","year":"2016","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jaci.2019.04.009_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaci.2015.06.022","article-title":"New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity","volume":"136","author":"Pirmohamed","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.04.009_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.tips.2016.11.003","article-title":"Genomics of adverse drug reactions","volume":"38","author":"Alfirevic","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jaci.2019.04.009_bib10","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cpt.1312","article-title":"Cost-effectiveness of panel tests for multiple pharmacogenes associated with adverse drug reactions: an evaluation framework","volume":"105","author":"Plumpton","year":"2019","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919305421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919305421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:19:35Z","timestamp":1758791975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919305421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0091674919305421"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.04.009","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA- and immune-mediated adverse drug reactions: Another hit with vancomycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.01.045","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}